MetfoRmin and its Effects on Myocardial Dimension and Left Ventricular Hypertrophy in Normotensive Patients with Coronary Artery Disease (MET-REMODEL Trial)

Project Details

StatusFinished
Effective start/end date1/10/1431/12/17

Funding

  • British Heart Foundation (PG/14/4/30539): £251,542.00